SAN DIEGO, Dec. 6, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabiscompany in the United States, today announced that its subsidiary Kannaway® has expanded full business operations into the European marketplace. Using European-sourced materials, the Company has created a distribution
Kannaway®, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, will be the first direct selling company to legally offer hemp-based CBD wellness products to the entire European market, where the market for organic foods is valued at €29.8 billion.
"We are extremely excited to take this next step in our international expansion by becoming the first direct selling company to feature phyto-cannabinoid based products in Europe and to share our products, culture and mission throughout Europe," said Medical Marijuana, Inc. Chief Operating Officer, Blake Schroeder. "We have always planned to bring our revolutionary products to a worldwide audience, and Europe is the perfect next step for our company."
Direct selling companies have been extremely successful in Europe, generating more than $35 billion in retail sales in 2015, according to The World Federation of Direct Selling Associations (WFDSA).
"There is already a huge sense of enthusiasm in the air when I meet with potential customers in Europe," said Kannaway® International Vice President Alex Grapov. "People are excited by the opportunity to get involved in our exploding industry with such a credible company and amazing product offering."
Information on Kannaway® in Europe or on how to become a European Kannaway® Brand Ambassador can be found at Kannaway.com/EU.
About Kannaway, LLCKannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMERThis press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT:Public Relations Contact:Andrew HardChief Executive Officer CMW MediaP. 888-829- firstname.lastname@example.org www.cmwmedia.com
View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-subsidiary-kannaway-announces-expansion-into-european-market-products-available-to-all-european-union-citizens-300567518.html
SOURCE Medical Marijuana, Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All